Role of microglia in glioma biology

Microscopy Research and Technique

Volumn 54, Issue 2, 2001, Pages 106-113

  Badie, Behnam ^a,b   Schartner, Jill ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Brain tumors; Malignant gliomas; Microglia

Indexed keywords

ANTIGEN-ANTIBODY REACTIONS; BRAIN; CELL CULTURE; CELL PROLIFERATION; CHEMICAL ACTIVATION; MACROPHAGES;

ACTIVATION PROCESS; BRAIN TUMORS; CELL POPULATIONS; CENTRAL NERVOUS SYSTEMS; MALIGNANT GLIOMA; MICROGLIA; PATHOLOGICAL CONDITIONS; PHAGOCYTOSE; PLASTIC CELLS; TISSUE MACROPHAGES;

TUMORS;

ANIMAL MODEL; ANTIGEN PRESENTATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL PROLIFERATION; DISEASE ASSOCIATION; FLOW CYTOMETRY; GLIOMA; IMMUNOMODULATION; LYMPHOCYTE ACTIVATION; MICROGLIA; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; TUMOR GROWTH; TUMOR PROMOTION;

EID: 0035879509     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1125     Document Type: Article

References (47)

1. Ambar BB, Frei K, Malipiero U, Morelli AE, Castro MG, Lowenstein PR, Fontana A. 1999. Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand. Hum Gene Ther 10:1641-1648.
2. Badie B, Schartner JM. 2000. Flow cytometric characterization of tumor-associated macrophages in experimental gliomas. Neurosurgery 46:957-961; discussion 961-952.
3. Badie B, Schartner J, Klaver J, Vorpahl J. 1999. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor. Neurosurgery 44:1077-1082; discussion 1082-1073.
4. Badie B, Schartner J, Prabakaran S, Paul J, Vorpahl J. 2001. Expression of Fas ligand by microglia: possible role in glioma immune evasion. (submitted)
5. Badie B, Schartner J, Vorpahl J, Preston K. 2000a. Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro. Exp Neurol 162:290-296.
6. Badie B, Schartner JM, Paul J, Bartley BA, Vorpahl J, Preston JK. 2000b. Dexamethasone-induced abolition of the inflammatory response in an experimental glioma model: a flow cytometry study. J Neurosurg 93:634-639.
7. Bechmann I, Mor G, Nilsen J, Eliza M, Nitsch R, Naftolin F. 1999. FasL (CD95L, Apo1L) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier. Glia 27:62-74.
8. Beutler AS, Banck MS, Wedekind D, Hedrich HJ. 1999. Tumor gene therapy made easy: allogeneic major histocompatibility complex in the C6 rat glioma model. Hum Gene Ther 10:95-101.
9. Brooks W, Marksbery W, Gupta G, Roszman T. 1978. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 4:219-224.
10. Burger P, Vogel F, Green S, Strike T. 1985. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 56:1106-1111.
11. Desbaillets I, Tada M, Tribolet N, Diserenis A, Hamou M, VanMeir E. 1994. Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer 58:240-247.
12. Di Renzo MF, Bertolotto A, Olivero M, Putzolu P, Crepaldi T, Schiffer D, Pagni CA, Comoglio PM. 1993. Selective expression of the Met/ HGF receptor in human central nervous system microglia. Oncogene 8:219-222.
13. Flugel A, Labeur MS, Grasbon-Frodl EM, Kreutzberg GW, Graeber MB. 1999. Microglia only weakly present glioma antigen to cytotoxic T cells. Int J Dev Neurosci 17:547-556.
14. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD. 1996. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med 184:1737-1745.
15. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. 1987. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur. J. Immunol. 17:1271-1278.
16. Frei K, Piani D, Malipiero UV, Van Meir E, de Tribolet N, Fontana A. 1992. Granulocyte-macrophage colony-stimulating factor (GM-CSF) production by glioblastoma cells. Despite the presence of inducing signals GM-CSF is not expressed in vivo. J Immunol 148:3140-3146.
17. Jaeckle KA. 1994. Immunotherapy of malignant gliomas. Semin Oncol 21:249-259.
18. Jeffers M, Rong S, Woude GF. 1996. Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis. J Mol Med 74:505-513.
19. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineburg E, Hudson EA, Resau JH, Vande Woude GF. 1997. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 57: 5391-5398.
20. Lee SC. 1994. GM-CSF Promotes Proliferation of Human Fetal and Adult Microglia in Primary Cultures. Glia 12:309-312.
21. Leung SY, Wong MP, Chung LP, Chan AS, Yuen ST. 1997. Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathologica 93:518-527.
22. Ling EA, Wong WC. 1993. The origin and nature of ramified and amoeboid microglia: a historical review and current concepts. Glia 7:9-18.
23. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer EG. 1993. Microglia in degenerative neurological disease. Glia 7:84-92.
24. Merrill J, Zimmerman R. 1991. Natural and induced cytotoxicity of oligodendrocytes by microglia is inhibitable by TGF β. Glia 4:327-331.
25. Moore S, Thanos S. 1996. The concept of microglia in relation to central nervous system disease and regeneration. Prog Neurobiol 48:441-460.
26. Morantz RA, Wood GW, Foster M, Clark M, Gollahon K. 1979a. Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. J Neurosurg 50:298-304.
27. Morantz RA, Wood GW, Foster M, Clark M, Gollahon K. 1979b. Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. J Neurosurg 50:305-311.
28. Morioka T, Baba T, Black KL, Streit WJ. 1992. Inflammatory cell infiltrates vary in experimental primary and metastatic brain tumors. Neurosurgery 30:891-896.
29. O'Keefe GM, Nguyen VT, Benveniste EN. 1999. Class II transactivator and class II MHC gene expression in microglia: modulation by the cytokines TGF-beta, IL-4, IL-13 and IL-10. Eur J Immunol 29:1275-1285.
30. Parney IF, Farr-Jones MA, Chang LJ, Petruk KC. 2000. Human glioma immunobiology in vitro: implications for immunogene therapy. Neurosurgery 46:1169-1177; discussion 1177-1168.
31. Paulus W, Roggendorf W, Kirchner T. 1992. Ki-M1P as a marker for microglia and brain macrophages in routinely processed human tissues. Acta Neuropathol 84:538-544.
32. Prados MD, Berger MS, Wilson CB. 1998. Primary central nervous system tumors: advances in knowledge and treatment [see comments]. CA Cancer J Clin 48:331-360, 321.
33. Raghavendra Rao VL, Dogan A, Bowen KK, Dempsey RJ. 2000. Traumatic brain injury leads to increased expression of peripheral-type benzodiazepine receptors, neuronal death, and activation of astrocytes and microglia in rat thalamus. Exp Neurol 161:102-114.
34. Roggendorf W, Strupp S, Paulus W. 1996. Distribution and characterization of microglia/macrophages in human brain tumors. Acta Neuropathol 92:288-293.
35. Rossi ML, Hughes JT, Esiri MM, Coakham HB, Brownell DB. 1987. Immunohistological study of mononuclear cell infiltrate in malignant gliomas. Acta Neuropathol 74:269-277.
36. Saas P, Walker PR, Hahne M, Quiquerez AL, Schnuriger V, Perrin G, French L, Van Meir EG, de Tribolet N, Tschopp J, Dietrich PY. 1997. Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain? J Clin Invest 99:1173-1178.
37. Sedgwick JD, Schwender S, Imrich H, Dorries R, Butcher GW, ter Meulen V. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc Natl Acad Sci USA 88:7438-7442.
38. Sedgwick JD, Ford AL, Foulcher E, Airriess R. 1998. Central nervous system microglial cell activation and proliferation follows direct interaction with tissue-infiltrating T cell blasts. J Immunol 160: 5320-5330.
39. Shinonaga M, Chang CC, Suzuki N, Sato M, Kuwabara T. 1988. Immunohistological evaluation of macrophage infiltrates in brain tumors. Correlation with peritumoral edema. J Neurosurg 68:259-265.
40. Streit WJ. 1994. Cellular immune response in brain tumors. Neuropathol Appl Neurobiol 20:205-206.
41. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. 1993. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151:2150-2158.
42. Tran CT, Wolz P, Egensperger R, Kosel S, Imai Y, Bise K, Kohsaka S, Mehraein P, Graeber MB. 1998. Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance. Neuropathol Appl Neurobiol 24:293-301.
43. Wagner S, Czub S, Greif M, Vince GH, Suss N, Kerkau S, Rieckmann P, Roggendorf W, Roosen K, Tonn JC. 1999. Microglial/macrophage expression of interleukin 10 in human glioblastomas. Int J Cancer 82:12-16.
44. Wierzba-Bobrowicz T, Kuchna I, Matyja E. 1994. Reaction of microglial cells in human astrocytomas (preliminary report). Folia Neuropathol 32:251-252.
45. Yamada T, Tsubouchi H, Daikuhara Y, Prat M, Comoglio PM, McGeer PL, McGeer EG. 1994. Immunohistochemistry with antibodies to hepatocyte growth factor and its receptor protein (c-MET) in human brain tissues. Brain Res 637:308-312.
46. Yamagata T, Muroya K, Mukasa T, Igarashi H, Momoi M, Tsukahara T, Arahata K, Kumagai H, Momoi T. 1995. Hepatocyte growth factor specifically expressed in microglia activated Ras in the neurons, similar to the action of neurotrophic factors. Biochem Biophys Res Commun 210:231-237.
47. Yoshimura T, Robinson EA, Tanaka S, Appella E, Kuratsu J, Leonard EJ. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J Exp Med 169:1449-1459.